| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |